Skip to content

Octapharma Produtos Farmacêuticos (Portugal)

Request correction

Portuguese arm of Octapharma, the world's largest private and independent plasma fractionation company.

Last updated September 15, 2026

AI crawler reads

2requests

1companies
  • Anthropic2
Profile
2
Controversies
0
JSON · MD
0
First read
Nov 4, 2026
Latest read
Nov 4, 2026

From this site's server log

Overview

Octapharma - Produtos Farmacêuticos, Lda. is the Portuguese entity of Octapharma, described on its Portuguese website as the world's largest private and independent plasma fractionation company. The group develops and produces medicines based on human plasma proteins and human cell lines across three therapeutic areas: Haematology, Immunotherapy and Intensive Care. Octapharma is a family company created in 1983 and headquartered in Lachen, Switzerland, with medicines marketed in 118 countries.

History

Octapharma is described as a family company created in 1983 and headquartered in Lachen, Switzerland. In 2018 it celebrated 35 years of commitment. The Portuguese entity is named Octapharma - Produtos Farmacêuticos, Lda.

Products and positioning

Maior empresa fracionadora de plasma privada e independente a nível mundial

  • Medicines derived from human plasma proteins and human cell lines

    Developed and produced across three therapeutic areas: Haematology, Immunotherapy and Intensive Care.

Sources4 sources

Cite this profile: Cite the canonical profile. /brand-wiki/octapharma-produtos-farmacêuticos-portugal · Editorial policy · How profiles are compiled